Press

Newsroom

Contact
press@imprimedicine.com
Follow
Download
Press Kit

Featured articles

ImpriMed is Revolutionizing Canine Cancer Treatment with Precision and Personalization
TechCrunch

Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology

Read More →
ImpriMed is Revolutionizing Canine Cancer Treatment with Precision and Personalization
USA Today

ImpriMed’s Transformative, Personal Approach to Canine Cancer Treatment

Read More →
ImpriMed is Revolutionizing Canine Cancer Treatment with Precision and Personalization
International Business Times

ImpriMed: Revolutionizing Canine Cancer Treatment with Precision and Personalization

Read More →
Meet ImpriMed, Mayo Clinic just welcomed to its AI accelerator program
MedCity News

Meet the 7 startups Mayo Clinic just welcomed to its AI accelerator

Read More →

Latest Stories

Button Text
In the News
Button Text
Presentations
Button Text
Press Releases
Button Text
Scientific Publications
Button Text
Video/Podcast Interviews
In the News
dvm360 logo

Flow cytometry and clonality evaluation are effective for characterizing feline lymphoma

DVM360
Learn More →
Press Releases
Business Wire Logo

ImpriMed Unveils Groundbreaking Cell-Sizing Method for High-Accuracy Feline Lymphoma Characterization in Veterinary Sciences

Business Wire
Learn More →
Scientific Publications
Veterinary Sciences Logo

Prognostic Utility of the Flow Cytometry and Clonality Analysis Results for Feline Lymphomas

Veterinary Sciences
Learn More →
In the News
Pulse 2.0 Logo

ImpriMed: Providing Personalized Medicine For Pets With Blood Cancer Diseases In A $1+ Billion Market

Pulse 2.0
Learn More →
In the News
Today's Veterinary Business

New AI Tool Guides Canine Cancer Treatment

Today's Veterinary Business
Learn More →
In the News
AVMA News

Artificial intelligence poised to transform veterinary care

AVMA News
Learn More →
In the News
DVM360 logo

New AI service offers personalized drug response predictions for canine patients with cancer

DVM360
Learn More →
Press Releases
BusinessWire Logo

ImpriMed Launches Innovative AI-Driven Drug Response Predictions (DRP) Service to Guide Tailored Treatments, Meet Rising Demand in Veterinary Oncology

Business Wire
Learn More →
Presentations
SAVY Logo

Improving Canine Lymphoma Treatment Outcomes by Individualizing Drug Selection using Machine-Learning-Based Predictive Models

Symposium on Artificial Intelligence in Veterinary Medicine (SAVY)
Learn More →
Press Releases
BusinessWire Logo

ImpriMed to Showcase Groundbreaking AI Research and Applications at Symposium on Artificial Intelligence in Veterinary Medicine (SAVY)

Business Wire
Learn More →
Presentations
WVCC Logo

Treatment-specific risk stratification of feline lymphoma based on unsupervised clustering of flow cytometry results

World Veterinary Cancer Congress 2024
Learn More →
Presentations
WVCC logo

Dramatically increased clinical remission rates and survival times in dogs with high-grade T-cell lymphoma and relapsed B-cell lymphoma in clinical study of AI decision support

World Veterinary Cancer Congress 2024
Learn More →
Press Releases
BusinessWire Logo

ImpriMed to Present Innovative Research at 2024 World Veterinary Cancer Congress

Business Wire
Learn More →
Scientific Publications
Frontiers in Oncology

Multimodal machine learning models identify chemotherapy drugs with prospective clinical efficacy in dogs with relapsed B-cell lymphoma

Frontiers in Oncology
Learn More →
Presentations
PMWC 2024

AI-driven Personalized Medicine for Cancer Care

Precision Medicine World Conference 2024
Learn More →
In the News
TechCrunch Logo

Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology

TechCrunch
Learn More →
Press Releases
Business Wire Logo

ImpriMed Raises $23 Million Series A Round to Expand its Revolutionary AI-Powered Cancer Treatment Technology

Business Wire
Learn More →
Presentations
Veterinary Cancer Society Logo

Increased survival and remission rates in prospective study of relapsed B-cell lymphoma patients treated by oncologists using ImpriMed's AI predictions

Veterinary Cancer Society Annual Conference 2023
Learn More →